Ubs Group Ag Geo Vax Labs, Inc. Transaction History

Ubs Group Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$0.51 - $0.62 $9,329 - $11,342	18,294 Added 2523.31%	19,019 $9,000
Q2 2023 Aug 11, 2023	SELL	$0.55 - $0.75 $7,630 - $10,405	-13,874 Reduced 95.03%	725 $0
Q1 2023 May 12, 2023	BUY	$0.62 - $1.11 $9,051 - $16,204	14,599 New	14,599 $9,000
Q2 2022 Aug 10, 2022	BUY	$9.29 - $34.8 $39,166 - $146,716	4,216 New	4,216 $4,000
Q1 2022 May 16, 2022	SELL	$17.25 - $58.95 $77,659 - $265,392	-4,502 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$52.65 - $71.7 $141,365 - $192,514	2,685 Added 147.77%	4,502 $16,000
Q3 2021 Nov 15, 2021	BUY	$56.4 - $91.35 $102,478 - $165,982	1,817 New	1,817 $8,000
Q1 2021 May 12, 2021	SELL	$49.05 - $126.6 $100,601 - $259,656	-2,051 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$39.45 - $85.95 $80,911 - $176,283	2,051 New	2,051 $7,000

Ticker GOVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,744,000
Market Cap $73M
Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.